Breakthrough Stem Cell Therapy Restores Vision in Corneal Patients
A groundbreaking clinical trial in Japan has successfully used induced pluripotent stem cells (iPSCs) to restore vision in patients with limbal stem cell deficiency (LSCD), a condition causing corneal damage. The trial involved transplanting iPSC-derived corneal epithelial cell sheets onto the corneas of four patients, resulting in significant vision improvements for three of them. This marks a world-first achievement in stem cell research, offering hope for new treatments for corneal vision loss, though further research is needed to ensure safety and efficacy.
